Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

被引:0
作者
Inge R. H. M. Konings
Stefan Sleijfer
Ron H. J. Mathijssen
Peter de Bruijn
Inge M. Ghobadi Moghaddam-Helmantel
Linda M. van Dam
Erik A. C. Wiemer
Jaap Verweij
Walter J. Loos
机构
[1] Erasmus University Medical Center,Department of Medical Oncology
来源
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词
Microdialysis; Pharmacokinetics; Target site; 5-Fluorouracil;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1055 / 1062
页数:7
相关论文
共 116 条
[1]  
Zamboni WC(2008)Tumor, tissue and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts Cancer Chemother Pharmacol 62 417-426
[2]  
Strychor S(2007)Plasma, tumor, and tissue disposition disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts Clin Cancer Res 13 7217-7223
[3]  
Joseph E(1999)Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines Cancer Chemother Pharmacol 43 269-276
[4]  
Parise RA(2002)Science, medicine, and the future: microdialysis Br Med J 324 588-591
[5]  
Egorin MJ(2007)Drug resistance and the solid tumor microenvironment J Natl Cancer Inst 99 1441-1454
[6]  
Eiseman JL(1994)Association of intratumor pharmacokinetics of fluorouracil with clinical response Lancet 343 1184-1187
[7]  
Zamboni WC(2004)High interstitial fluid pressure—an obstacle in cancer therapy Nat Rev Cancer 10 803-813
[8]  
Strychor S(1997)5-Fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients Cancer Res 57 2598-2601
[9]  
Joseph E(2003)Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer Br J Cancer 88 782-787
[10]  
Zamboni WC(2003)Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer Clin Pharmacol Ther 73 417-426